Published October 17, 2025
| Version v1
Journal article
Open
Pharmacists' and physicians' knowledge and attitude regarding deprescribing in Saudi Arabia
Authors/Creators
- 1. Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
- 2. King Fahad Specialist Hospital, Dammam, Saudi Arabia
- 3. Prince Mohammed bin Fahd Specialist Hospital for blood diseases, Dammam, Saudi Arabia
- 4. King Faisal University, Alhofuf, Saudi Arabia
Description
Study Objectives: Our study objectives were to test pharmacists' and physicians' knowledge and attitude towards deprescribing in Saudi Arabia.
Methods: A survey-based cross-sectional study was performed to answer our research question. We collected study data through a validated survey assessing deprescribing knowledge and attitude, including all pharmacists and physicians who care for older adults or have an interest in this patient population. Data were analyzed using IBM SPSS v27.0. Continuous variables were reported as mean ± SD, and categorical variables were reported as percentages and frequencies. Knowledge level (high vs. low–moderate) was compared across gender, experience quartile, academic degree, and professional role using χ² tests with Cramer's V and a Bonferroni-corrected α = 0.0125, while attitude was modeled with a forced-entry multiple linear regression including knowledge, age, years of experience, and gender.
Results: In total, 238 participants (pharmacists and physicians) completed the survey. The majority were male (65%) and had 4 years' experience (53%). In addition, 31% worked in community pharmacy, 25% in hospital pharmacy, while physicians represented 31% of study participants. We found a significant positive correlation between knowledge and attitude towards deprescribing, and the majority of participants demonstrated moderately positive attitudes, aligning with the observed knowledge–attitude relationship.
Conclusion: Our findings indicate that the majority of healthcare provider participants had a low to moderate level of knowledge about deprescribing.
Files
PHAR_article_168634.pdf
Files
(407.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:d648d0a5488d3150fe0fb4a5d4d2799e
|
301.5 kB | Preview Download |
|
md5:f934f76e44213a138c52d043088a618e
|
105.7 kB | Preview Download |
Additional details
References
- Abou J, Crutzen S, Tromp V, Heringa M, Van Marum R, Elders P, Taxis K, Denig P, Hugtenburg J (2022) Barriers and enablers of healthcare providers to deprescribe cardiometabolic medication in older patients: A focus group study. Drugs & Aging 39(3): 209–221. https://doi.org/10.1007/s40266-021-00918-7
- Adams AJ, Eid DD (2024) Toward collaborative practice, not collaborative practice agreements. American Journal of Health-System Pharmacy 81(7): e157–e158. https://doi.org/10.1093/ajhp/zxad280
- Albabtain B, Hadi MA, Bawazeer G, Alqahtani A, Bahatheq A, Alhossan A, Cheema E (2021) Evaluation of a community pharmacy-based medication therapy management programme: A study protocol of a pilot randomized controlled trial with an embedded qualitative study. Saudi Pharmaceutical Journal 29(7): 706–712. https://doi.org/10.1016/j.jsps.2021.05.001
- Alharthi MS (2025) Barriers and facilitators to proactive deprescribing in Saudi hospitals: A qualitative study using the theoretical domains framework. Healthcare 13(11): e1274. https://doi.org/10.3390/healthcare13111274
- Alqurain AA, Albaharnah M, Al Zayer S, Ameer L, Ghosn S, Al-Shaibi S, Algoraini M, Aldhafeeri A, Alyusuf DA, Alshnbari A, Alsaffar N, Al-Matouq J, Al Khamees M, AlAlwan B, Alomar FA (2024) The prevalence of polypharmacy and hyper-polypharmacy among middle-aged vs. older patients in Saudi Arabia: A cross-sectional study. Frontiers in Pharmacology 15: e1357171. https://doi.org/10.3389/fphar.2024.1357171
- Alrasheed MM, Alhawassi TM, Alanazi A, Aloudah N, Khurshid F, Alsultan M (2018) Knowledge and willingness of physicians about deprescribing among older patients: A qualitative study. Clinical Interventions in Aging 13: 1401–1408. https://doi.org/10.2147/CIA.S165588
- Bacci JL, Coley KC, McGrath K, Abraham O, Adams AJ, McGivney MS (2016) Strategies to facilitate the implementation of collaborative practice agreements in chain community pharmacies. Journal of the American Pharmacists Association 56(3): 257–265. https://doi.org/10.1016/j.japh.2016.02.014
- Campbell NL, Pitts C, Corvari C, Kaehr E, Alamer K, Chand P, Nanagas K, Callahan CM, Boustani MA (2022) Deprescribing anticholinergics in primary care older adults: Experience from two models and impact on a continuous measure of exposure. Journal of the American College of Clinical Pharmacy 5(10): 1039–1047. https://doi.org/10.1002/jac5.1682
- Chae J, Cho HJ, Yoon S-H, Kim D-S (2024) The association between continuous polypharmacy and hospitalization, emergency department visits, and death in older adults: A nationwide large cohort study. Frontiers in Pharmacology 15: e1382990. https://doi.org/10.3389/fphar.2024.1382990
- Doherty AJ, Boland P, Reed J, Clegg AJ, Stephani A-M, Williams NH, Shaw B, Hedgecoe L, Hill R, Walker L (2020) Barriers and facilitators to deprescribing in primary care: A systematic review. BJGP Open 4(3): bjgpopen20X101096. https://doi.org/10.3399/bjgpopen20X101096
- Hu X, Liu R, Tang L, Mei M, Li Y, Tang G, Feng J, Chen W, Li G (2024) Physicians and hospital pharmacists' knowledge, attitudes, and practices towards polypharmacy in older patients with chronic diseases. Scientific Reports 14(1): 1–11. https://doi.org/10.1038/s41598-024-80989-9
- Hurley E, Dalton K, Byrne S, Foley T, Walsh E (2024) Pharmacist-led deprescribing using STOPPFrail for frail older adults in nursing homes. Journal of the American Medical Directors Association 25(9): e105122. https://doi.org/10.1016/j.jamda.2024.105122
- Jungo KT, Mantelli S, Rozsnyai Z, Missiou A, Kitanovska BG, Weltermann B, Mallen C, Collins C, Bonfim D, Kurpas D, Petrazzuoli F, Dumitra G, Thulesius H, Lingner H, Johansen KL, Wallis K, Hoffmann K, Peremans L, Pilv L, Šter MP, Bleckwenn M, Sattler M, van der Ploeg M, Torzsa P, Kánská PB, Vinker S, Assenova R, Bravo RG, Viegas RPA, Tsopra R, Pestic SK, Gintere S, Koskela TH, Lazic V, Tkachenko V, Reeve E, Luymes C, Poortvliet RKE, Rodondi N, Gussekloo J, Streit S (2021) General practitioners' deprescribing decisions in older adults with polypharmacy: A case vignette study in 31 countries. BMC Geriatrics 21(1): 1–12. https://doi.org/10.1186/s12877-020-01953-6
- Kerelos T, Gangoo-Dookhan T (2023) The impact of pharmacists engaged in collaborative practice agreements in the United States. Journal of Pharmacy Practice 36(6): 1480–1484. https://doi.org/10.1177/08971900221116684
- Linsky A, Gellad WF, Linder JA, Friedberg MW (2019) Advancing the science of deprescribing: A novel comprehensive conceptual framework. Journal of the American Geriatrics Society 67(10): 2018–2022. https://doi.org/10.1111/jgs.16136
- Mantelli S, Jungo KT, Rozsnyai Z, Reeve E, Luymes CH, Poortvliet RKE, Chiolero A, Rodondi N, Gussekloo J, Streit S (2018) How general practitioners would deprescribe in frail oldest-old with polypharmacy – The LESS study.". BMC Family Practice 19(1): 1–8. https://doi.org/10.1186/s12875-018-0856-9
- Martin B, Phoenix BJ, Chapman SA (2020) How collaborative practice agreements impede the provision of vital behavioral health services. Nursing Outlook 68(5): 581–590. https://doi.org/10.1016/j.outlook.2020.04.002
- McDonald EG, Wu PE, Rashidi B, Wilson MG, Bortolussi-Courval É, Atique A, Battu K, Bonnici A, Elsayed S, Wilson AG, Papillon-Ferland L, Pilote L, Porter S, Murphy J, Ross SB, Shiu J, Tamblyn R, Whitty R, Xu J, Fabreau G, Haddad T, Palepu A, Khan N, McAlister FA, Downar J, Huang AR, MacMillan TE, Cavalcanti RB, Lee TC (2022) The MedSafer study – electronic decision support for deprescribing in hospitalized older adults: A cluster randomized clinical trial. JAMA Internal Medicine 182(3): 265–273. https://doi.org/10.1001/jamainternmed.2021.7429
- Ní Chróinín D, Ní Chróinín C, Beveridge A (2015) Factors influencing deprescribing habits among geriatricians. Age and Ageing 44(4): 704–708. https://doi.org/10.1093/ageing/afv028
- Quek HW, Page A, Lee K, Lee G, Hawthorne D, Clifford R, Potter K, Etherton‐Beer C (2024) The effect of deprescribing interventions on mortality and health outcomes in older people: An updated systematic review and meta‐analysis. British Journal of Clinical Pharmacology 90(10): 2409–2482. https://doi.org/10.1111/bcp.16200
- Rasheed MK, Hasan SS, Alqasoumi A, Babar ZU-D (2023) Impact of an educational program on community pharmacist's preparedness to conduct pharmacist-led diabetes clinic in Saudi Arabia. Journal of Pharmaceutical Policy and Practice 16(1): 1–87. https://doi.org/10.1186/s40545-023-00597-2
- Thompson W, McDonald EG (2024) Polypharmacy and deprescribing in older adults. Annual Review of Medicine 75(1): 113–127. https://doi.org/10.1146/annurev-med-070822-101947
- van Poelgeest EP, Seppala LJ, Lee JM, Bahat G, Ilhan B, Lavan AH, Mair A, van Marum RJ, Onder G, Ryg J, Fernandes MA, Garfinkel D, Guðmundsson A, Hartikainen S, Kotsani M, Montero-Errasquín B, Neumann-Podczaska A, Pazan F, Petrovic M, Soulis G, Vankova H, Wehling M, Wieczorowska-Tobis K, van der Velde N (2022) Deprescribing practices, habits and attitudes of geriatricians and geriatricians-in-training across Europe: A large web-based survey. European Geriatric Medicine 13(6): 1455–1466. https://doi.org/10.1007/s41999-022-00702-9
- Wang Z, Liu T, Su Q, Luo H, Lou L, Zhao L, Kang X, Pan Y, Nie Y (2024) Prevalence of polypharmacy in elderly population worldwide: A systematic review and meta‐analysis. Pharmacoepidemiology and Drug Safety 33(8): e5880. https://doi.org/10.1002/pds.5880
- Woodward MC (2003) Deprescribing: Achieving better health outcomes for older people through reducing medications. Journal of Pharmacy Practice and Research 33(4): 323–328. https://doi.org/10.1002/jppr2003334323
- Wu H, O'Donnell LK, Fujita K, Masnoon N, Hilmer SN (2021) Deprescribing in the older patient: A narrative review of challenges and solutions. International Journal of General Medicine 14: 3793–3807. https://doi.org/10.2147/IJGM.S253177